Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Prolonged oral etoposide as second-line therapy for platinum-resistant and platinum-sensitive ovarian carcinoma: a Gynecologic Oncology Group study.

PaperCitations, authors & open-access status

Prolonged oral etoposide as second-line therapy for platinum-resistant and platinum-sensitive ovarian carcinoma: a Gynecologic Oncology Group study. is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 404 citations, 1998 year and closed oa status.

404
Citations
1998
Year
closed
OA Status

Related on ScholarIQ

Peter G. Rose
Author
Journal of Clinical Oncology
Journal
Ovarian cancer diagnosis and treatment
Topic
Ovarian cancer diagnosis and treatment
Topic
PARP inhibition in cancer therapy
Topic
Lung Cancer Research Studies
Topic
470M+ articles · free account